Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Uterine Cervical Neoplasms 2Neuroblastoma 2Gliosarcoma 2Glioblastoma 2Ganglioneuroblastoma 2Vaginal Neoplasms 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Pinealoma 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive 1Meningioma 1Medulloblastoma 1Kidney Neoplasms 1Human Papillomavirus-Negative Neck Squamous Cell Carcinoma 1Glioma, Subependymal 1Glioma 1Esthesioneuroblastoma, Olfactory 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Ependymoma 1Craniopharyngioma 1Choroid Plexus Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Endometrioid 1Biochemically Recurrent Prostate Carcinoma 1Astrocytoma 1

Interventions

Magnetic Resonance Spectroscopy 3gallium 68 PSMA-11 1X-Rays 1Specimen Handling 1Radiation 1Photons 1Lutetium-177 1Congresses as Topic 168Ga-DKFZ-PSMA-11 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Biochemically Recurrent Prostate Carcinoma × Congresses as Topic × Clear all
NCT06105918 2025-12-09

Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients With Biochemically Recurrent Prostate Cancer

Emory University

Phase 1 Active not recruiting
6 enrolled
Genitourinary

Biochemically Recurrent Prostate Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡